Brand-labeled eucalyptus oil treated as patent medicine, making excise duty under Item 14E sustainable.

Eucalyptus oil marketed as "Vimtone" was treated as a patent or proprietary medicine under Item 14E of Schedule I to the Central Excise Act, 1944 because its packing and labelling bore a brand name and described it as a remedy for cold, headache and pains. The absence of the dealer's picture and signature did not alter the position, since the brand and trade presentation were sufficient to give the preparation a distinct identity and indicate a connection in the course of trade with the manufacturer. Excise duty under Item 14E was therefore sustainable against the assessee.

---

---

Issues: Whether the product marketed as eucalyptus oil under the brand name "Vimtone" was a patent or proprietary medicine falling under Item 14E of Schedule I of the Central Excise Act, 1944 and therefore liable to excise duty.

Analysis: Item 14E covered patent or proprietary medicines not containing alcohol or narcotic drugs, and the Explanation treated as such any medicinal preparation bearing a brand name or other mark used in trade to indicate a connection between the medicine and a particular person. The product was packed and labelled with the name "Vimtone" and described as a medicine for cold, headache and pains. Even though the dealer's picture and signature were absent, the branding and labelling were sufficient to give the preparation a distinct trade identity and to indicate a connection in the course of trade with the manufacturer.

Conclusion: The product was rightly treated as a patent or proprietary medicine, and the excise levy under Item 14E was sustainable, against the assessee.

---